Kornitzer Capital Management Inc Adaptive Biotechnologies Corp Transaction History

Kornitzer Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$10.12 - $28.9 $1.95 Million - $5.57 Million	-192,695 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$30.02 - $39.87 $13.1 Million - $17.4 Million	-436,405 Reduced 69.37%	192,695 $6.55 Million
Q1 2021 Apr 30, 2021	BUY	$37.26 - $67.74 $2.24 Million - $4.06 Million	60,000 Added 10.54%	629,100 $25.3 Million
Q4 2020 Jan 29, 2021	SELL	$45.01 - $65.47 $130,078 - $189,208	-2,890 Reduced 0.51%	569,100 $33.7 Million
Q3 2020 Oct 30, 2020	BUY	$35.79 - $48.81 $13.4 Million - $18.3 Million	375,490 Added 191.09%	571,990 $27.8 Million
Q2 2020 Aug 03, 2020	SELL	$24.95 - $48.38 $40,419 - $78,375	-1,620 Reduced 0.82%	196,500 $9.51 Million
Q1 2020 Apr 30, 2020	BUY	$16.96 - $34.16 $1.63 Million - $3.29 Million	96,170 Added 94.33%	198,120 $5.5 Million
Q4 2019 Jan 31, 2020	BUY	$24.56 - $32.8 $1.09 Million - $1.45 Million	44,320 Added 76.9%	101,950 $3.05 Million
Q3 2019 Nov 04, 2019	BUY	$30.31 - $53.51 $685,915 - $1.21 Million	22,630 Added 64.66%	57,630 $1.78 Million
Q2 2019 Jul 31, 2019	BUY	$40.3 - $48.3 $1.41 Million - $1.69 Million	35,000 New	35,000 $1.69 Million

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $726M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Kornitzer Capital Management Inc with notifications on news.